Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing

Lefterova, 2015, Next-generation sequencing for infectious disease diagnosis and management: a report of the Association for Molecular Pathology, J Mol Diagn, 17, 623, 10.1016/j.jmoldx.2015.07.004 Casadella, 2017, Deep sequencing for HIV-1 clinical management, Virus Res, 239, 69, 10.1016/j.virusres.2016.10.019 Kyeyune, 2016, Low-frequency drug resistance in HIV-infected Ugandans on antiretroviral treatment is associated with regimen failure, Antimicrob Agents Chemother, 60, 3380, 10.1128/AAC.00038-16 Stella-Ascariz, 2017, The role of HIV-1 drug-resistant minority variants in treatment failure, J Infect Dis, 216, S847, 10.1093/infdis/jix430 Mohamed, 2014, Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure, AIDS, 28, 1315, 10.1097/QAD.0000000000000267 Li, 2013, Clinical implications of HIV-1 minority variants, Clin Infect Dis, 56, 1667, 10.1093/cid/cit125 Li, 2011, Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis, JAMA, 305, 1327, 10.1001/jama.2011.375 Ávila-Rios, 2016, Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey, Lancet HIV, 3, e579, 10.1016/S2352-3018(16)30119-9 Tzou, 2018, Comparison of an in vitro diagnostic next-generation sequencing assay with Sanger sequencing for HIV-1 genotypic resistance testing, J Clin Microbiol, 56, e00105-18, 10.1128/JCM.00105-18 Chan, 2016, A novel system control for quality control of diagnostic tests based on next-generation sequencing, J Applied Lab Med, 1, 25, 10.1373/jalm.2016.020131 Paredes, 2017, Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation, PLoS One, 12, e0181357, 10.1371/journal.pone.0181357 Rhee, 2016, HIV-1 protease, reverse transcriptase, and integrase variation, J Virol, 90, 6058, 10.1128/JVI.00495-16 Li, 2010, Fast and accurate long-read alignment with Burrows-Wheeler transform, Bioinformatics, 26, 589, 10.1093/bioinformatics/btp698 Woods, 2012, Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool, J Clin Microbiol, 50, 1936, 10.1128/JCM.06689-11 Shafer, 2001, High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients, J Clin Microbiol, 39, 1522, 10.1128/JCM.39.4.1522-1529.2001 Raymond, 2018, HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform, J Antimicrob Chemother, 73, 1152, 10.1093/jac/dky003 Dessilly, 2018, First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium, PLoS One, 13, e0209561, 10.1371/journal.pone.0209561 Oster, 2017, Increasing HIV-1 subtype diversity in seven states, United States, 2006-2013, Ann Epidemiol, 27, 244, 10.1016/j.annepidem.2017.02.002 Hemelaar, 2019, Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis, Lancet Infect Dis, 19, 143, 10.1016/S1473-3099(18)30647-9 2017 Lapointe, 2015, HIV drug resistance testing by high-multiplex “wide” sequencing on the MiSeq instrument, Antimicrob Agents Chemother, 59, 6824, 10.1128/AAC.01490-15